Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.

MLA

Burghuber, Christopher K., et al. “Standardized Intraoperative Application of an Absorbable Polysaccharide Hemostatic Powder to Reduce the Incidence of Lymphocele after Kidney Transplantation - a Prospective Trial.” Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 32, no. 1, Jan. 2019, pp. 59–65. EBSCOhost, https://doi.org/10.1111/tri.13329.

APA

Burghuber, C. K., Kandioler, D., Strobl, S., Mittlböck, M., Böhmig, G. A., Soliman, T., & Berlakovich, G. A. (2019). Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial. Transplant International : Official Journal of the European Society for Organ Transplantation, 32(1), 59–65. https://doi.org/10.1111/tri.13329

Chicago

Burghuber, Christopher K, Daniela Kandioler, Stephanie Strobl, Martina Mittlböck, Georg A Böhmig, Thomas Soliman, and Gabriela A Berlakovich. 2019. “Standardized Intraoperative Application of an Absorbable Polysaccharide Hemostatic Powder to Reduce the Incidence of Lymphocele after Kidney Transplantation - a Prospective Trial.” Transplant International : Official Journal of the European Society for Organ Transplantation 32 (1): 59–65. doi:10.1111/tri.13329.